Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
about
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionThe therapy of gefitinib towards breast cancer partially through reversing breast cancer biomarker arginine.Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceEstablishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.Plasticity of tumor cell invasion: governance by growth factors and cytokines.Circulating tumor cells in breast cancer: applications in personalized medicine.Inhibition of Janus kinases by tyrosine phosphorylation inhibitor, Tyrphostin AG-490.Blood-based tumor biomarkers in lung cancer for detection and treatment.Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
P2860
Q28066285-5EB23B05-35CA-4FE2-A069-9547A239D6CDQ35780497-1D6118CB-8751-4309-A440-879E49B55B5EQ36048588-AD59A0C4-4F9E-4BDB-B5A6-20F0FB39C9E1Q36250585-33DF8E8A-4FE9-45FB-B455-8C1A6F647866Q38862668-71E58AF1-70CD-4D1D-BFB4-A893A91033A7Q38963431-D98F3B95-94C1-4F6D-913C-3A4BAF027934Q38985771-226FD2BD-101F-4AB9-87F8-F0FAD940A0ECQ40897166-9C32670C-5A8A-4618-9134-2DD9F1DDFCBEQ47126156-BD1B3B42-B558-43FA-AB16-01ED40E90628Q47130842-13F6C0B1-85AA-4BAF-BD54-EF6B0A679A9EQ49380125-AC146EB3-68BB-451C-895B-5738EEE4047AQ50199981-E9B10CDE-1FB5-4E78-9F34-2A693F4B0E6A
P2860
Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@en
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@nl
type
label
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@en
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@nl
prefLabel
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@en
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@nl
P2093
P2860
P1476
Elimination of EGFR-expressing ...... cancer treated with gefitinib.
@en
P2093
Alexandros Xyrafas
Antonia Kalykaki
Dimitris Mavroudis
Sofia Agelaki
Vassilis Georgoulias
P2860
P2888
P304
P356
10.1007/S00280-014-2387-Y
P577
2014-02-04T00:00:00Z